Roman Butler Fullerton & CO Pfizer Inc Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Pfizer Inc stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 34,463 shares of PFE stock, worth $946,353. This represents 0.3% of its overall portfolio holdings.

Number of Shares

34,463

Previous 50,378 31.59%

Holding current value

$946,353

Previous $1.41 Million 29.24%

% of portfolio

0.3%

Previous 0.48%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$27.7 - $31.39 $440,845 - $499,571	-15,915 Reduced 31.59%	34,463 $997,000
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $27,407 - $32,116	-1,085 Reduced 2.11%	50,378 $1.41 Million
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $706,046 - $810,766	-27,271 Reduced 34.64%	51,463 $1.43 Million
Q4 2023 Jan 31, 2024	BUY	$26.13 - $33.94 $621,449 - $807,195	23,783 Added 43.28%	78,734 $2.27 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $126,980 - $148,427	-3,957 Reduced 6.72%	54,951 $1.82 Million
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $478,048 - $553,090	-13,235 Reduced 18.35%	58,908 $2.16 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $629,649 - $819,710	15,985 Added 28.46%	72,143 $2.94 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $140,238 - $183,065	3,359 Added 6.36%	56,158 $0
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $96,753 - $118,111	2,211 Added 4.37%	52,799 $2.21 Million
Q2 2022 Jul 26, 2022	SELL	$46.53 - $55.17 $30,011 - $35,584	-645 Reduced 1.26%	50,588 $2.62 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $10,019 - $12,415	-219 Reduced 0.43%	51,233 $2.65 Million
Q4 2021 Jan 24, 2022	SELL	$41.32 - $61.25 $33,510 - $49,673	-811 Reduced 1.55%	51,452 $3.04 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $5,612 - $7,210	-143 Reduced 0.27%	52,263 $2.16 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $3,375 - $3,823	94 Added 0.18%	52,406 $2.05 Million
Q1 2021 Apr 22, 2021	BUY	$33.49 - $37.77 $45,747 - $51,593	1,366 Added 2.68%	52,312 $1.97 Million
Q4 2020 Feb 01, 2021	SELL	$33.47 - $42.56 $60,312 - $76,693	-1,802 Reduced 3.42%	50,946 $1.88 Million
Q3 2020 Oct 15, 2020	BUY	$31.75 - $37.25 $13,176 - $15,458	415 Added 0.79%	52,748 $1.94 Million
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $110,600 - $134,174	-3,672 Reduced 6.56%	52,333 $1.71 Million
Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $368,175 - $526,043	-13,621 Reduced 19.56%	56,005 $1.83 Million
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $270,569 - $307,061	8,219 Added 13.38%	69,626 $2.73 Million
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $67,644 - $87,714	-2,082 Reduced 3.28%	61,407 $2.21 Million
Q2 2019 Jul 22, 2019	BUY	$36.98 - $41.52 $130,576 - $146,607	3,531 Added 5.89%	63,489 $2.75 Million
Q1 2019 Apr 24, 2019	BUY	$37.5 - $41.2 $481,725 - $529,255	12,846 Added 27.27%	59,958 $2.55 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $1.81 Million - $2.07 Million	47,112 New	47,112 $1.99 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Pfizer Inc Transaction History